About the Islet Cell Carcinoma Session
Islet cell carcinoma, also known as pancreatic neuroendocrine tumor (PNET), is a rare type of cancer originating in the islet cells of the pancreas, which produce hormones like insulin and glucagon. Research in this field focuses on understanding the genetic and molecular mechanisms driving the development and progression of these tumors. Scientists investigate potential biomarkers for early detection, as well as targeted therapies to improve treatment outcomes. Immunotherapy and combination therapies are emerging as promising approaches. Additionally, advancements in imaging techniques aid in accurate diagnosis and monitoring of the disease. Collaborative efforts between researchers, clinicians, and patients are crucial for advancing knowledge and developing effective strategies to combat islet cell carcinoma.
Topics Covered in Islet Cell Carcinoma
Insulinoma & Gastrinoma
Nonfunctional Tumors
Hereditary Syndromes
Pancreatic Resection
Somatostatin Analogs
Radioligand Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Islet Cell Carcinoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Islet Cell Carcinoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Islet Cell Carcinoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Islet Cell Carcinoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Islet Cell Carcinoma Conference 2027 — FAQs
What is the Islet Cell Carcinoma track at CIOC 2027?
The Islet Cell Carcinoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Islet Cell Carcinoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Islet Cell Carcinoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Islet Cell Carcinoma are all welcome — whether presenting or attending.
Can I present my research in the Islet Cell Carcinoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Islet Cell Carcinoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Islet Cell Carcinoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.